Omkar Pharmachem Ltd.
Snapshot View

21.30 ▼0%

10 May 2022, 04:01:00 PM

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.omkarpharmachem.co.in
Market Cap 21.48 Cr.
Enterprise Value(EV) 22.20 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 0.47 Trailing Twelve Months Ending 2021-12
Price-Earning Ratio (PE) 45.80 Trailing Twelve Months Ending 2021-12
Industry PE 29.69 Trailing Twelve Months Ending 2021-12
Book Value / Share 8.77 Trailing Twelve Months Ending 2021-12
Price to Book Value 2.43 Calculated using Price: 21.30
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 1.01 Cr. 10,084,800 Shares
FaceValue 10
Company Profile
The company is engaged in the manufacturing of pharmaceutical chemicals.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
1 Week
1 Month
3 Month
+0.71%
6 Month
-5.96%
1 Year
+7.04%
2 Year
+22.41%
5 Year
+141.50%
10 Year
+285.87%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) -0.13 0.04 -0.66 -1.27 2.38 -2.77 -4.72 -3.03 2.59
Return on Capital Employed (%) -0.13 0.04 -0.66 -1.27 2.91 -2.55 -4.11 -2.22 0.22
Return on Assets (%) -0.13 0.04 -0.65 -1.22 2.30 -2.72 -4.49 -2.78 2.36

Balance Sheet View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 9 9 9 9 9 9 9 8 9 9
Non Curr. Liab. 0 0 0 0 0
Curr. Liab. 0 0 0 1 0 0 1 1 1 1
Minority Int.
Equity & Liab. 9 9 9 10 9 9 9 9 9 10
Non Curr. Assets 9 9 9 9 9 9 9 9 9 9
Curr. Assets 0 0 0 0 0 0 0 0 0 0
Misc. Exp. not W/O
Total Assets 9 9 9 10 9 9 9 9 9 10

Profit Loss View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 0 0 0 0 1
Other Income 0
Total Income 0 0 0 0 0 1
Total Expenditure 0 0 0 0 0 0 0 0 0 0
PBIDT 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0
Depreciation
Taxation 0 0 0
Exceptional Items 0
PAT 0 0 0 0 0 0 0 0 0
Adjusted EPS 0 0 0 0 0 0 0 0 0

Cash Flow View Details

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 0 -1 0 0 0 0
Cash Fr. Inv. 0 0 0
Cash Fr. Finan. 0 0 0 0 0 0
Net Change 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0

Shareholding Pattern View Details

9 Qtrs 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%)
Promoter 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03
Public 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Mon, 13 Jun 2022
Results-Financial Results For March 31 2022
Dear Sir Pursuant to Regulation 23 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed the disclosure of Related Party Transactions for the half year ended March 31 2022.
Tue, 31 May 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Dear Sir Please find enclosed herewith copy of newspapers advertisement in which Audited financial results for the quarter and Year ended on 31stMarch2022 are published one in vernacular language and one in English newspaper.
Mon, 30 May 2022
Board Meeting Outcome for Outcome Of The Board Meeting Held On 30Th May 2022
Dear Sir Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 please note that the Board in their meeting held on 30th May 2022 has considered and approved the following business:1. Audited Financial Results of the Company for the quarter and year ended on 31st March 2022.

Technical Scans View Details

No Scans Found

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 197,729.19 824.10 -0.1%
Divi's Laboratories Ltd. 97,465.46 3,671.45 +0.1%
Cipla Ltd. 75,288.48 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. 71,702.79 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. 55,150.04 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. 48,693.19 2,877.70 +0.8%
Gland Pharma Ltd. 42,987.55 2,610.75 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 60.42 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 32.92 3,671.45 +0.1%
Cipla Ltd. Consolidated 2022-03 29.92 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 32.85 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 52.24 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 62.67 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2022-03 35.48 2,610.75 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 4.12 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8.31 3,671.45 +0.1%
Cipla Ltd. Consolidated 2022-03 3.61 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 3.73 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 9.78 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8.18 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2022-03 6.01 2,610.75 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 0.08 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 3,671.45 +0.1%
Cipla Ltd. Consolidated 2021-03 0.10 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 0.62 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 0.84 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2021-03 0.00 2,610.75 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,671.45 +0.1%
Cipla Ltd. Consolidated 2021-03 14.13 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,610.75 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,671.45 +0.1%
Cipla Ltd. Consolidated 2021-03 14.13 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,610.75 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 33,498.14 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 3,671.45 +0.1%
Cipla Ltd. Consolidated 2021-03 19,159.59 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 10,560.00 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 8,004.83 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2021-03 3,462.88 2,610.75 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 2,284.68 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 3,671.45 +0.1%
Cipla Ltd. Consolidated 2021-03 2,401.30 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 136.00 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 1,251.88 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2021-03 996.96 2,610.75 +0.1%

FAQ's On Omkar Pharmachem Ltd.

Can I Buy Omkar Pharmachem Shares now?

What is the Share Price of Omkar Pharmachem?

What is the Relative Strength Index (RSI) Value of Omkar Pharmachem?

What is the Market Capital (MCAP) of Omkar Pharmachem?

What are the key metrics to analyse Omkar Pharmachem?